Clinical trials
Recruiting Cardiomyopathies trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 9 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 4 |
| Rocket Pharmaceuticals Inc. | 4 |
| Vanderbilt University Medical Center | 4 |
| Lexeo Therapeutics | 3 |
| Weill Medical College of Cornell University | 3 |
| Alnylam Pharmaceuticals | 2 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| Johns Hopkins University | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Stanford University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 45 |
| Heart Failure | 14 |
| Heart Diseases | 9 |
| Amyloidosis | 6 |
| Arrhythmias, Cardiac | 6 |
| Cardiovascular Diseases | 6 |
| Arrhythmogenic Right Ventricular Dysplasia | 5 |
| Cardiomyopathy, Hypertrophic | 5 |
| Death, Sudden, Cardiac | 5 |
| Amyloid Neuropathies, Familial | 4 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.